| [1] |
ZHANG Yuting, ZHAO Huixia, MENG Xin, ZHAO Jiale, HE Xiaoyuan.
Changes of skin and intestinal microflora in psoriasis mice based on 16S rRNA sequencing
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 15-20.
|
| [2] |
DU Baiyinzi, WANG Huiping, LUO Suju.
Efficacy and safety comparation of adalimumab and secukinumab in the treatment of nail psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 26-30.
|
| [3] |
LEI Mingjun, DU Yinghua, TIAN Zan, BAI Fan.
Secukinumab in the treatment of plaque psoriasis complicated with uveitis: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 45-47.
|
| [4] |
ZHENG Chunzhi, ZHANG Weilin, GUO Xiao, YANG Baoqi, YANG Qing, LIU Hong.
Efficacy and safety of ixekizumab and adalimumab in the treatment of moderate to severe plaque psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(9): 633-638.
|
| [5] |
YUAN Jinxiang, WANG Tianxue, ZHANG Junling.
Research progress of deucravacitinib in the treatment of psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(9): 693-697.
|
| [6] |
CHEN Wenjie, ZHOU Shengji, CHEN Shengli, LIU Hong, ZHANG Furen.
CARD14-associated papulosquamous eruption caused by a novel mutation: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(8): 580-582.
|
| [7] |
LUO Huiqing, MA Juan, FU Chao, QIAO Meng, XIN Linlin.
Research progress of exosomal circRNAs in psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(8): 619-624.
|
| [8] |
GUO Shufen, WU Jiahui, LIU Boyan, CHEN Wenwen, GENG Biao, LIU Zhichao.
Effects of hydrogen on proliferation of HaCaT keratinocytes and expression of inflammatory factors
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(7): 501-504.
|
| [9] |
ZI Jiaqi, DENG Danqi.
Neural and immune mechanism of pruritus in psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(7): 543-547.
|
| [10] |
DIAO Ziyue, XIA Ruiyuan, YIN Zhiqiang.
Update of targeted therapy for localized pustular psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(6): 456-460.
|
| [11] |
SANG Xu, WANG Zhenzhen, LI Wenchao, LIU Hong, ZHANG Furen.
Cost-effectiveness analysis of biologic agents in the treatment of moderate-to-severe plaque psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 344-349.
|
| [12] |
CAO Shan, SUN Yonghu, ZHAO Qing, LIU Hong, ZHANG Furen.
IL-17 inhibitor treated a specific type of psoriasis resistant to TNF-α inhibitor
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 353-354.
|
| [13] |
SHI Linli, YAN Shaochen, BI Xinling.
Update of paradoxical reactions induced by commonly used biological agents in psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(3): 201-205.
|
| [14] |
LIU Jian, ZHANG Zhiqin, YIN Zhiqiang.
Update of relationship between regulated cell death and psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(3): 206-211.
|
| [15] |
LU Zixuan, WU Jianhua.
Update of extracellular vesicles in psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(3): 218-222.
|
